Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712803 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Infections Causing Human Cancer' returned 78 results - Page 1 of 4

 FEATURED RESULTS
Drug Delivery in Cancer - Technologies, Markets and Companies

Cancer Diagnostic Testing World Markets

Antibody Drug Target Atlas in Oncology

Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Eval...

DNA Repair in Cancer Therapy. Molecular Targets and Clinical...


  Sort by   
  Sorted by Rank Top-Bottom

Cytogenetics - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 225
and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies


Animal Biotechnology - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 348
Introduction Infections in animals Viral infections Avian influenza Animal surveillance of influenza Animal biotechnology implications of H1N1 influenza Animal corona viruses and human SARS Avian


Biomarkers - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 864
as biomarker of disease Vitamin D as a biomarker of disease Vitamin B12 deficiency Biomarkers of gene-environmental interactions in human disease 6. Biomarkers of Cancer Introduction The ideal biomarker


Molecular Diagnostics - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 1029
and purposes Emerging infections Human vs. non-human infections Genetics and susceptibility to infectious disease Molecular epidemiology of cancer Molecular epidemiology of p53 gene mutations Molecular


Personalized Medicine - Scientific and Commercial Aspects  
Jain PharmaBiotech, Feb 2012, Pages: 780
for specific therapeutic areas described in the report. Examples of this are genotyping for drug resistance in HIV infection, personalized therapy of cancer, antipsychotics for schizophrenia, antidepressant


Systemic Fungal Infection Therapeutics Research – Malaysia  
Frost & Sullivan, Oct 2009, Pages: 42
, that is, solid organ transplant, cancer, neonates, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), and surgical patients. 1 | EXECUTIVE SUMMARY - Malaysia -- 1. Executive Summary


Systemic Fungal Infection Therapeutics Market – India  
Frost & Sullivan, Nov 2009, Pages: 43
manufacturers need to develop drugs that address specific indications, in terms of pathogen coverage and patient groups, that is, solid organ transplant, cancer, neonates, human immunodeficiency virus/acquired


Systemic Fungal Infection Therapeutics Market - South Korea  
Frost & Sullivan, Oct 2009, Pages: 43
, that is solid organ transplant, cancer, neonates, human immunodeficiency virus (HIV)/AIDS, and surgical patients. 1 | EXECUTIVE SUMMARY - Overview -- 1. Executive Summary 2 | SYSTEMIC FUNGAL INFECTION


Systemic Fungal Infection Therapeutics Market - Australia  
Frost & Sullivan, Nov 2009, Pages: 45
that address specific indications in terms of pathogen coverage and patient groups, that is, solid organ transplant, cancer, neonates, human immunodeficiency virus (HIV)/AIDS, and surgical patients. 1


Systemic Fungal Infection Therapeutics Market- Taiwan  
Frost & Sullivan, Nov 2009, Pages: 40
indications in terms of pathogen coverage and patient groups i.e. solid organ transplant, cancer, neonates, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), and surgical patients. 1


RNAi - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 485
of therapeutic applications include virus infections, cancer, genetic disorders and neurological diseases. Research at academic centers that is relevant to RNAi-based therapeutics is mentioned. Regulatory


Nitric Oxide - Therapeutics, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 276
of NO in the human body Table 4-1: Diseases involving nitric oxide Table 4-2: Role of nitric oxide in pathogenesis of autoimmune disorders Table 4-3: Role of nitric oxide in infections Table 5-1: Neuroprotective


Nanobiotechnology Applications, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 772
of the safety concerns associated with the fate of nanoparticles introduced into the human body. Numerous nanodevices and nanosystems for sequencing single molecules of DNA are feasible. Various nanodiagnostics


Antiviral Therapeutics - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 481
) and human papilloma virus (HPV). There a number of treatments but HSV is not destroyed completely and remains dormant and activates from time to time to cause various clinical manifestations


Systemic Fungal Infection Therapeutics Market Research – Philippines  
Frost & Sullivan, Oct 2009, Pages: 43
indications in terms of pathogen coverage and patient groups, i.e. solid organ transplant, cancer, neonates, human immunodeficinecy virus/acquired immunodeficiency syndrome (HIV/AIDS), and surgical patients. 1


Cancer Therapies - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2011, Pages: 897
Topoisomerase inhibitors 46 Risks Associated with Chemotherapy 47 When Chemotherapy Fails 47 9. AN OVERVIEW OF CANCERS 48 Cancer: A Major Health Crisis in the Modern World 48 Table 11: Cancer Causes


Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009  
Life Science Intelligence, Inc., Dec 2009, Pages: 1763
- Phototherapy/ultraviolet light to inactivate the organisms that cause nail infections - Human Globin, a biopolymer to replace animal collagens in dermal fillers and create biomaterials for tissue repair


Competitor Analysis: HPV Vaccines  
La Merie, May 2010, Pages: 18
common sexually transmitted infections (STI). Two vaccines are commercially available to protect females against the types of HPV that cause most cervical cancers. One of these vaccines also protects


Human Papillomavirus Infections - Pipeline Review, H2 2011  
Global Markets Direct, Oct 2011, Pages: 99
Human Papillomavirus Infections - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Human Papillomavirus Infections - Pipeline Review, H2 2011', provides an overview of the Human


Cytology and HPV Testing World Markets  
TriMark Publications, Jan 2011, Pages: 156
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by both external (chemicals


Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds